Sit Investment Associates Inc. Sells 7,700 Shares of Cabot Corporation $CBT

Sit Investment Associates Inc. lowered its stake in shares of Cabot Corporation (NYSE:CBT) by 43.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 10,000 shares of the specialty chemicals company’s stock after selling 7,700 shares during the quarter. Sit Investment Associates Inc.’s holdings in Cabot were worth $663,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. DGS Capital Management LLC bought a new position in Cabot in the fourth quarter valued at $206,000. Pacer Advisors Inc. lifted its stake in Cabot by 3,165.7% during the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after purchasing an additional 222,232 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Cabot by 1.8% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 547,410 shares of the specialty chemicals company’s stock worth $36,283,000 after purchasing an additional 9,816 shares in the last quarter. Caitlin John LLC boosted its holdings in shares of Cabot by 29.3% in the 4th quarter. Caitlin John LLC now owns 3,137 shares of the specialty chemicals company’s stock worth $208,000 after purchasing an additional 710 shares in the last quarter. Finally, Beacon Pointe Advisors LLC bought a new position in shares of Cabot during the 4th quarter valued at about $1,640,000. 93.18% of the stock is owned by institutional investors.

Cabot Price Performance

Shares of Cabot stock opened at $91.43 on Friday. The firm has a market cap of $4.72 billion, a PE ratio of 17.28, a price-to-earnings-growth ratio of 12.07 and a beta of 0.82. Cabot Corporation has a 12-month low of $58.33 and a 12-month high of $91.80. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The company’s fifty day simple moving average is $81.52 and its two-hundred day simple moving average is $74.78.

Cabot (NYSE:CBT) last released its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.30 million. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities analysts expect that Cabot Corporation will post 6.34 EPS for the current year.

Cabot Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a dividend of $0.4725 per share. The ex-dividend date was Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. This is a boost from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio (DPR) is presently 35.73%.

Wall Street Analyst Weigh In

CBT has been the topic of a number of research reports. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a research report on Sunday, June 14th. Mizuho lifted their price target on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. UBS Group boosted their price objective on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. Finally, Truist Financial assumed coverage on shares of Cabot in a research note on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective for the company. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $83.80.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.